Surgery Partners (SGRY) director awarded 11,670 restricted shares vesting in 2027

Rhea-AI Filing Summary

ADLERZ CLIFFORD G reported acquisition or exercise transactions in this Form 4 filing.

Surgery Partners, Inc. director Clifford G. Adlerz reported an equity award of common stock under the company’s compensation program. He received 11,670 shares of common stock at a reference price of $13.71 per share as a grant, not an open-market purchase. Following this award, his directly held stake increased to 69,104 shares of Surgery Partners common stock. The granted shares are subject to vesting and will fully vest on June 5, 2027.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider ADLERZ CLIFFORD G

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11,670	$13.71	$160K

Holdings After Transaction: Common Stock — 69,104 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares granted: 11,670 shares Grant reference price: $13.71 per share Total shares after transaction: 69,104 shares +1 more

4 metrics

Shares granted 11,670 shares Equity award of common stock on June 5, 2026

Grant reference price $13.71 per share Recorded price for the June 5, 2026 stock award

Total shares after transaction 69,104 shares Direct holdings of Clifford G. Adlerz following the grant

Vesting date June 5, 2027 All 11,670 granted shares vest on this date

Key Terms

Grant, award, or other acquisition, Common Stock, vesting, Form 4

4 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

vesting financial

"Shares will vest on June 5, 2027."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ADLERZ CLIFFORD G

(Last) (First) (Middle)

C/O SURGERY PARTNERS, INC.

340 SEVEN SPRINGS WAY, SUITE 600

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Surgery Partners, Inc. [ SGRY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/05/2026		A		11,670(1)	A	$13.71	69,104	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares will vest on June 5, 2027.

Remarks:

	/s/ Jennifer Baldock, Attorney-in-Fact	06/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Surgery Partners (SGRY) report for Clifford G. Adlerz?

Surgery Partners director Clifford G. Adlerz reported receiving 11,670 shares of common stock as an equity award. The grant was recorded at $13.71 per share and is a compensation-related acquisition rather than an open-market stock purchase.

Was the Surgery Partners (SGRY) insider transaction a stock purchase or a grant?

The transaction was a stock grant, not an open-market purchase. Clifford G. Adlerz received 11,670 common shares as a compensation award recorded at $13.71 per share, classified as a “Grant, award, or other acquisition” in the Form 4 filing.

How many Surgery Partners (SGRY) shares does Clifford G. Adlerz hold after this grant?

After the reported grant, Clifford G. Adlerz directly holds 69,104 shares of Surgery Partners common stock. This total includes the 11,670 newly awarded shares reported in the Form 4 and reflects his direct ownership position following the transaction.

At what price was the Surgery Partners (SGRY) equity award to Clifford G. Adlerz recorded?

The 11,670-share equity award to Clifford G. Adlerz was recorded at $13.71 per share. This price in the Form 4 serves as the grant’s reference value, reflecting the share value used for compensation accounting rather than an open-market trade price.

When will Clifford G. Adlerz’s new Surgery Partners (SGRY) shares vest?

The granted shares are subject to time-based vesting conditions. According to the footnote, all 11,670 shares awarded to Clifford G. Adlerz will vest on June 5, 2027, assuming the vesting conditions set by Surgery Partners are satisfied.